Senior Director, Search & Evaluation Late TA Lead, Immunology
Main Responsibilities & Accountabilities
Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning.
Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs.
Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL’s therapeutic areas.
NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations.
Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics.
Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy.
Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions.
Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution.
Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities.
Qualifications & Experience Requirements
- 15+ years in biopharma with significant experience in clinical development, external innovation, or business development.
- Advanced degree required (MD, PhD, or equivalent).
- Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas.
- Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks.
- Strong understanding of regulatory pathways, market access, and competitive standards of care.